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E3 ubiquitin ligase Cbl-b plays a crucial role in T cell
activation and tolerance induction. However, the
molecular mechanism by which Cbl-b inhibits T cell
activation remains unclear. Here, we report that
Cbl-b does not inhibit PI3K but rather suppresses
TCR/CD28-induced inactivation of Pten. The
elevated Akt activity in Cbl-b/ T cells is therefore
due to heightened Pten inactivation. Suppression of
Pten inactivation in T cells by Cbl-b is achieved by
impeding the association of Pten with Nedd4, which
targets Pten K13 for K63-linked polyubiquitination.
Consistent with this finding, introducing Nedd4 defi-
ciency into Cbl-b/ mice abrogates hyper-T cell
responses caused by the loss of Cbl-b. Hence, our
data demonstrate that Cbl-b inhibits T cell activation
by suppressing Pten inactivation independently of its
ubiquitin ligase activity.INTRODUCTION
Casitas B-lineage lymphoma protein b (Cbl-b) belongs to the Cbl
family. It contains multiple functional domains, including a
protein tyrosine kinase-binding (TKB) domain, a RING finger
(RF) domain, and a proline-rich region, as well as a ubiquitin
(Ub)-associated domain. The RF domain is the site whereby
Cbl family proteins recruit Ub-conjugating enzymes, which add
Ub to targeted proteins. The TKB domain has been shown to
recognize specific phosphotyrosine residues on target proteins
for Ub conjugation (Sawasdikosol et al., 2000; Rao et al., 2002;
Zhang, 2004). These domains are required for Cbl family proteins
to regulate signaling transduction and protein degradation. Gene
targeting in mice has indicated a critical role for Cbl-b in the
maintenance of a balance between immunity and tolerance472 Cell Reports 1, 472–482, May 31, 2012 ª2012 The Authors(Bachmaier et al., 2000; Chiang et al., 2000). Loss of Cbl-b
relieves a T cell from requiring CD28 costimulation for prolifera-
tion and IL-2 production (Bachmaier et al., 2000; Chiang et al.,
2000), suggesting that Cbl-b may be involved in CD28-depen-
dent T cell activation. Indeed, our previous studies indicate
that CD28 and CTLA-4 tightly regulate Cbl-b expression, which
is critical for establishing the threshold for T cell activation (Li
et al., 2004; Zhang et al., 2002). In strong support of this notion,
Cbl-b has been reported to be crucial for T cell anergy induction
in vitro and in vivo (Heissmeyer et al., 2004; Jeon et al., 2004).
At the molecular level, Cbl-b has been suggested to target
p85, a regulatory subunit of PI3K, for ubiquitination, which
results in its failure to associate with the CD28 and TCR-z chains
(Fang and Liu, 2001). Therefore, it has been proposed that elim-
ination of Cbl-b may favor CD28-mediated Vav-1 activation
(Bachmaier et al., 2000; Chiang et al., 2000) possibly through
a PI3K-dependent mechanism (Fang and Liu, 2001; Fang
et al., 2001). Recent studies suggest that Phosphatase and ten-
sin homolog deleted on chromosome 10 (Pten) is also involved in
CD28 costimulation (Buckler et al., 2006). Pten was identified as
a tumor suppressor that is mutated in a large number of cancers
at high frequency (Salmena et al., 2008). Pten specifically cata-
lyzes the dephosphorylation of the 30 phosphate of the inositol
ring in phosphatidylinositol (3,4,5)-trisphosphate (PIP3), resulting
in the biphosphate product phosphatidylinositol (4,5)-bisphos-
phate (PIP2) (Cantley and Neel, 1999; Chalhoub and Baker,
2009; Rommel et al., 2007). This dephosphorylation is important
because it results in inhibition of the Akt signaling pathway. Pten
deficiency in T cells negates the requirement of CD28 costimula-
tion for optimal T cell activation, and Pten/ T cells are resistant
to T cell anergy induction in vitro and in vivo (Buckler et al., 2006),
reminiscent of the Cbl-b/ T cell phenotype. In support of a crit-
ical role of Pten in T cell tolerance, loss of Pten or downregulation
of Pten expression results in the development of autoimmunity
(Di Cristofano et al., 1999; Suzuki et al., 2001). Pten has been
shown to be regulated by multiple posttranslational modifica-
tions such as phosphorylation, acetylation, oxidation, and
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Figure 1. Loss of Cbl-b Results in Elevated Levels of Cellular PIP3
and Akt Activation in T Cells
WT and Cbl-b/ T cells were stimulated with anti-CD3 or anti-CD3 plus anti-
CD28 for 0, 1, and 5 min, or were pretreated with LY294002 (40 mM) and then
stimulated with anti-CD3 for 5 min as an assay control. Neutral lipids from
these cells were extracted, and PIP3 levels were detected using a PIP3 mass
ELISA kit. The lysates of the aforementioned cells were blotted with anti-
phospho-Akt (S473), and membrane was stripped and reprobed with anti-Akt
(upper panel). Alternatively, WT and Cbl-b/ T cells were stimulated with anti-
CD3 for 1 min, and the stimulation was stopped by adding cold PBS. Surface
expression of PIP3 was determined by staining with anti-PIP3 Ab and analyzed
by flow cytometry (lower panel). Mean fluorescence intensity (MFI) was
quantified (n = 3 per group). Values are mean ± SEM. The data are one
representative of three independent experiments. See also Figure S1.ubiquitination (Salmena et al., 2008). Neural precursor cell
expressed, developmentally downregulated 4 (Nedd4), a HECT
E3 Ub ligase, has been shown to target Pten for ubiquitination
in cancer cells (Wang et al., 2007). Although Nedd4 has been
implicated in T cell anergy induction in vitro, Nedd4/ T cells
fail to proliferate in vitro in response to TCR stimulation, and
Nedd4/ fetal liver chimeric mice display defective immune
response to antigen in vivo (Yang et al., 2008), suggesting that
Nedd4 positively regulates T cell activation. However, the
precise molecular mechanism by which Nedd4 regulates T cell
activation remains to be defined.
Although hyper-PI3K activation was implicated in T cells lack-
ing Cbl-b following TCR stimulation, phosphorylation of Akt was
used as a readout for PI3K activity (Fang and Liu, 2001), and the
direct analysis of PI3K activity in Cbl-b/ T cells was not
performed in previous studies. Furthermore, the enhancement
of PI3K activity induced by CD28 costimulation was determined
using phosphotyrosine or CD28 immunoprecipitates (Cai et al.,
1995; Hutchcroft et al., 1995; Lu et al., 1994; Naramura et al.,
1998; Page`s et al., 1994, 1996), or p85 or Akt phosphorylation
as a readout (Fang and Liu, 2001; Lu et al., 1994; Kane et al.,
2001; King et al., 2006), and the role of other factors such as
Pten cannot be excluded in these assays. Because Akt is nega-
tively regulated by Pten, whether the aberrant accumulation of
PIP3 and subsequent heightened activation of Akt in Cbl-b
/
T cells result from reduced Pten activity remains to be further
elucidated.
In this study we attempted to determine the relative contribu-
tions of PI3K and Pten to accumulation of PIP3 and Akt activation
in Cbl-b/ T cells upon TCR stimulation. Our data clearly show
that Cbl-b does not regulate PI3K but rather suppresses TCR/
CD28-induced inactivation of Pten. Cbl-b inhibits TCR-induced
ubiquitination of Nedd4, which targets Pten K13 for K63-linked
polyubiquitination. Thus, Cbl-b modulates Pten activation, inde-
pendently of its Ub ligase activity.
RESULTS
Loss of Cbl-b Results in Aberrant Accumulation of PIP3
and Heightened Activation of Akt upon TCR Stimulation
We have previously shown that loss of Cbl-b leads to aberrant
activation of Akt upon TCR stimulation (Qiao et al., 2008). To
determinewhether loss of Cbl-b results in aberrant accumulation
of PIP3 in cells, we measured PIP3 levels in the lysates of
wild-type (WT) and Cbl-b/ T cells before and after stimulation
using a PIP3 mass ELISA kit. PIP3 levels were elevated in WT
T cells in response to TCR stimulation andwere further increased
by CD28 costimulation. In contrast, Cbl-b/ T cells displayed
heightened PIP3 levels upon TCR stimulation without CD28
costimulation (Figure 1, upper panel). In correlation with this
observation, Akt was hyperphosphorylated in response to TCR
stimulation in Cbl-b/ T cells (Qiao et al., 2008) (Figure 1, upper
panel). The increased PIP3 levels in Cbl-b
/ T cells following
TCR stimulation were confirmed with detection of PIP3 levels
by flow cytometry (Figure 1, lower panel). The elevated PIP3
levels and heightened Akt phosphorylation in the absence
of Cbl-b were not due to the higher basal levels of T cell
activation in Cbl-b/ mice because Cbl-b/ T cells expressedsimilar levels of CD44 and CD62L compared to WT T cells
(Figure S1).
Heightened Levels of PIP3 Induced by TCR Stimulation
in the Absence of Cbl-b Are Due to Down-Modulation
of Pten Activity
To determine the cause of the heightened cellular PIP3 levels in
the absence of Cbl-b, we directly measured PI3K activity in
WT and Cbl-b/ T cells stimulated as in Figure 1. We repeatedly
observed that there was no significant increase in PI3K activity in
T cells lacking Cbl-b upon TCR stimulation compared to WT
T cells, and CD28 costimulation did not further enhance PI3K
activity in bothWT and Cbl-b/ T cells (Figure 2A). Furthermore,
transfecting Cbl-b/ T cells with catalytically active form of PI3K
p110 with or without Cbl-b did not alter PI3K activity (Figure 2B).
Our data strongly indicate that Cbl-b does not inhibit PI3K in
T cells, and CD28 costimulation does not directly promote
PI3K activity, although cellular PIP3 levels are potentiated by
CD28 costimulation.
Cbl-b has been shown to target PI3K p85 for ubiquitination in
Jurkat T cells, and ubiquitinated p85 fails to bind to TCR-z and
CD28 (Fang and Liu, 2001). However, ubiquitination of p85 was
not abrogated in primary mouse T cells lacking Cbl-b (Fig-
ure S2A). Furthermore, we did not observe an increasedCell Reports 1, 472–482, May 31, 2012 ª2012 The Authors 473
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Figure 2. Elevated PIP3 Production and Akt Activation in Cbl-b
/
T Cells Are Not Due to Increased PI3K Activity but Rather Down-
regulation of Pten Activation
(A) WT and Cbl-b/ T cells (2 3 107) were stimulated with anti-CD3 or anti-
CD3 plus anti-CD28 for 0, 1, and 5 min, and lysed. The cell lysates were
immunoprecipitated with anti-p85, and PI3K activity associated with p85
immunoprecipitates was detected using a competitive ELISA. Half of the p85
immunoprecipitates and an aliquot of the cell lysates from each sample were
blotted with anti-p85 and anti-actin, respectively.
(B) Cbl-b/ T cells were transfected with Myr-(iSH2-p85)-p110a-Myc with or
without HA-taggedCbl-b, stimulated with anti-CD3, and lysed. The cell lysates
were immunoprecipitated with anti-Myc, and the PI3K activity was deter-
mined. An aliquot of the cell lysates was blotted with anti-Myc, anti-HA, and
anti-actin, respectively.
(C) WT and Cbl-b/ T cell lysates treated as in (A) were immunoprecipitated
with anti-Pten or a control IgG, and Pten activity was detected by a Pten ELISA
kit. Recombinant Pten was used as a positive control. Half of the Pten
immunoprecipitates from each sample and an aliquot of the cell lysates were
blotted with anti-Pten and anti-actin, respectively.
The data are representative of at least three independent experiments. See
also Figure S2.
474 Cell Reports 1, 472–482, May 31, 2012 ª2012 The Authorsrecruitment of p85 to TCR-z and CD28 following TCR stimulation
in Cbl-b/ T cells (Figure S2B) as described by Fang and Liu
(2001). Surprisingly, Pten inducibly or constitutively associated
with TCR-z or CD28 (Figure S2B), suggesting that previously
reported PIP3 measurement using CD28 or phosphotyrosine
immunoprecipitates cannot be used as an indicator for PI3K
activity.
Because Pten dephosphorylates PIP3 to PIP2, thus inhibiting
Akt activation, we then wanted to test the idea that decreased
Pten activity in Cbl-b/ T cells may be responsible for aberrant
activation of Akt. Therefore, we directly measured Pten activity.
Intriguingly, Pten activity was downregulated by TCR stimula-
tion in WT T cells, and CD28 costimulation further suppressed
Pten activation (Figure 2C). In contrast, TCR-induced downre-
gulation of Pten activation was significantly potentiated in
Cbl-b/ T cells, and loss of Cbl-b uncoupled the requirement
of CD28 costimulation from downregulation of Pten activity
(Figure 2C). Taken together, our data indicate that augmented
PIP3 levels and Akt activity in Cbl-b
/ T cells upon TCR stim-
ulation are not due to enhanced PI3K activation but rather
reduced Pten activity. In support of our observations, it has
been shown that the T cell requirement for CD28 costimulation
is due to negative regulation of TCR signals by Pten (Buckler
et al., 2006).
Cbl-b Inhibits Ubiquitination of Pten Mediated by Nedd4
Having shown that Cbl-b inhibits Pten inactivation in T cells, we
next attempted to determine howCbl-b regulates this process. It
has been shown that Pten undergoes posttranslational modifica-
tions including ubiquitination (Wang et al., 2007; Salmena et al.,
2008). We then investigated whether Cbl-b may be directly or
indirectly involved in Pten ubiquitination. Surprisingly, the
absence of Cbl-b led to enhanced ubiquitination of Pten upon
TCR stimulation (Figure 3A). However, increased ubiquitination
of Pten did not lead to its degradation in WT and Cbl-b/
T cells (Figure 3B, upper panel). In contrast to previous reports
that Pten was induced or downregulated by CD28 costimulation
(Schmidt-Weber et al., 2002; Jindra et al., 2010), we found that
Pten mRNA expression was slightly decreased in both WT and
Cbl-b/ T cells costimulated by CD3/CD28, but this decrease
did not reach statistical significance (Figure 3B, lower panel).
Our data suggest that Pten may undergo K63-linked polyubiqui-
tination in T cells. This notion was confirmed using a newly devel-
oped K63-specific Ub antibody (Ab) for immunoblotting (Fig-
ure 3C, upper panel). To further verify that Pten undergoes
K63-linked polyubiquitination upon TCR stimulation, we tran-
siently transfected a mouse thymocyte hybridoma cell line
(DO11.10 T cells) with Flag-tagged Pten, Myc-tagged Nedd4,
and HA-tagged WT Ub, Ub K48R, or K63R, and stimulated
them with anti-CD3 and anti-CD28. As shown in the lower panel
of Figure 3C, stimulation of T cells with anti-CD3 and anti-CD28
induced K63 but not K48-linked polyubiquitination of Pten,
further indicating that Pten ubiquitination in T cells occurs
predominantly in a K63-dependent manner.
It has been shown that Nedd4 is the E3 Ub ligase for Pten in
cancer cells (Wang et al., 2007). The enhanced ubiquitination
of Pten in the absence of Cbl-b raised the possibility that Cbl-b
targets Nedd4 for ubiquitination. Intriguingly, we found that the
loss of Cbl-b did not impair but significantly enhanced Nedd4
ubiquitination (Figure 3D, upper panel), but Nedd4 ubiquitination
did not result in its degradation (Figure 3D, lower panel). These
data suggest that Cbl-b may inhibit TCR-induced Nedd4 ubiqui-
tination. Because Nedd4 autoubiquitination represents its E3 Ub
ligase activity, we then decided to examine the effect of Cbl-b on
Nedd4 E3 Ub ligase activity. To this end, we performed in vitro
Nedd4 autoubiquitination assays in the presence or absence of
Cbl-b. We also included Cbl-b C373A mutant protein, which
cannot bind to the E2-Ub complex, to exclude the possibility
that Cbl-b may sequester the E2-Ub complex from Nedd4. As
expected, the presence of Cbl-b or Cbl-b C373A protein greatly
inhibited Nedd4 autoubiquitination (Figure 3E). These data
suggest that Cbl-b regulates Nedd4 Ub ligase activity indepen-
dently of its RF domain. In support of this observation, T cells
harboring Cbl-b RF C373A point mutation, which abrogates its
E3 Ub ligase activity, displayed normal levels of Akt activation
(Figure 3F), strongly supporting the notion that Cbl-b regulates
Pten/Akt independently of its E3 Ub ligase activity. Interestingly,
TCR-induced phosphorylation of IKK-a/b and its substrate IkBa,
but not ERK, JNK, or p38 MAPK, was heightened in Cbl-bC373A
T cells (Figure S3A), suggesting that inhibition of the NF-kB
pathway by Cbl-b in T cells is dependent upon its E3 Ub ligase
activity. Note that although Akt phosphorylationwas comparable
between WT and Cbl-bC373A T cells, the latter displayed height-
ened proliferation in response to lower doses of anti-CD3 stimu-
lation, whereas a high dose of anti-CD3 (20 mg/ml) induced equal
levels of T cell proliferation (Figure S3B). This result suggests that
Cbl-b RF mutation lowers the threshold for T cell activation,
possibly via a NF-kB-dependent mechanism. Our data are
consistent with a recent report that showed that injection of
p33 peptide into P14.Cbl-bC373A mice results in a 75% death
rate, whereas the same injection leads to a 100% death rate in
P14.Cbl-b/ mice (Paolino et al., 2011).
To confirm whether the presence of Cbl-b affects Nedd4-
mediated Pten K63-linked ubiquitination, we performed an
in vitro Pten ubiquitination assay. We incubated GST-Pten with
Nedd4 isolated from T cells stimulated or unstimulated with
anti-CD3 and anti-CD28, together with HA-Cbl-b C373A, E1,
E2, and K63 Ub. After reaction, Pten was precipitated with
anti-GST, and blotted with anti-K63 Ub. The addition of Cbl-b
C373A mutated protein significantly inhibited K63-linked Pten
ubiquitination (Figure 3G). Taken together, our data suggest
that loss of Cbl-b releases its inhibitory effect on Nedd4 E3 Ub
ligase activity, thus strongly eliciting K63-linked polyubiquitina-
tion of Pten induced by TCR stimulation (Figure 3A).
Lysine 13 Is the Major Ubiquitination Site for Pten
in T Cells
It has been well documented that K289 and K13 are the major
sites for Pten monoubiquitination in cancer cell lines (Trotman
et al., 2007). We wanted to determine whether mutation of
Pten at K289 or K13 abrogated Pten polyubiquitination in
T cells. To this end, we cotransfected DO11.10 T cells with
HA-tagged Pten, Pten K289R, or K13R mutants together with
Myc-tagged Nedd4 and His-tagged Ub, and stimulated them
with or without anti-CD3 plus anti-CD28. We found that Pten
K13R mutant but not K289R mutant abrogated TCR/CD28-induced Pten ubiquitination (Figure 4A), suggesting that K13 is
the major ubiquitination site of Pten in response to TCR stimula-
tion. To demonstrate whether mutation of Pten K13 renders Pten
active, we performed a Pten phosphatase activity assay. Indeed,
Pten K13R mutant-transfected T cells displayed heightened
activity compared to WT or K289R-mutated Pten-transfected
T cells (Figure 4B). This observation is supported by a recent
report that Pten ubiquitination inhibits its phosphatase activity
(Maccario et al., 2010). Consistent with this observation, immu-
nofluorescence staining showed that Pten K13R was predomi-
nantly located at the plasma membrane compared to WT Pten
or Pten K289R mutant upon TCR/CD28 stimulation (Figure 4C),
suggesting that Pten at the plasma membrane is catalytically
more active.
Loss of Cbl-b Facilitates Pten Cytoplasmic Retention
upon TCR Stimulation
It has been shown thatmembrane localization of Pten is essential
for its catalytic activity toward the conversion of the membrane
lipid PIP3 to PIP2, whereas cytoplasmic Pten may be enzymati-
cally inactive (Chalhoub and Baker, 2009). Pten may undergo
monoubiquitination, which regulates Pten nuclear import and is
essential for tumor suppression (Trotman et al., 2007). Polyubi-
quitination, in contrast, results in cytoplasmic Pten retention
(Trotman et al., 2007). To evaluate whether Cbl-b regulates
Pten subcellular localization, we isolated the membrane and
cytosolic fractions fromWT and Cbl-b/ T cells before and after
TCR or TCR/CD28 stimulation (Qiao et al., 2010; Salojin et al.,
1997). Although Pten was located in either the plasma
membrane or cytoplasm of resting WT and Cbl-b/ T cells,
membrane-associated Pten was reduced in WT T cells upon
TCR stimulation, and this process was heightened in the pres-
ence of CD28 costimulation (Figure 5A). In contrast, TCR stimu-
lation induced a strong cytosolic translocation of Pten from the
plasma membrane in the absence of Cbl-b and uncoupled the
requirement for this translocation from CD28 costimulation (Fig-
ure 5A). To further investigate whether membrane-targeted Pten
is enzymatically active, we transfected DO11.10 T cells with Pten
protein artificially targeted to the plasma membrane by the addi-
tion of the N-terminal myristoylation/palmitoylation signal from
Lck (Myr-tagged Pten) (Maccario et al., 2010). Indeed, Myr-
tagged Pten displayed higher basal levels of Pten activity
compared to WT-untagged Pten and failed to be downregulated
upon TCR/CD28 stimulation (Figure 5B), suggesting that Pten at
the membrane is more active. Our data suggest that K63-linked
polyubiquitination regulated by Cbl-b may regulate subcellular
localization and activity of Pten in T cells. It has been reported
that the membrane targeting through N-terminal myristoylation
enhances ubiquitination of Pten and inhibits its phosphatase
activity (Maccario et al., 2010), which appear to be contradictory
with our data. This discrepancy may be due to different types of
modulations of Pten by K48- or K63-linked ubiquitination and/or
different types of cells (T cells versus tumor cell line). It should be
noted that although most Pten is located in the plasma
membrane in resting T cells, it does not undergo ubiquitination
spontaneously. Pten ubiquitination in T cells requires TCR trig-
gering. Nevertheless, both K48- and K63-linked Pten ubiquitina-
tions inhibit its phosphatase activity.Cell Reports 1, 472–482, May 31, 2012 ª2012 The Authors 475
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Figure 3. Elevated Ubiquitination of Pten in Cbl-b/ T Cells Is Mediated by Nedd4
(A) WT and Cbl-b/ T cells were pretreated with MG-132 (5 mM) for 30 min, stimulated with anti-CD3 or anti-CD3 plus anti-CD28 for 0, 1, and 5 min, and lysed in
RIPA buffer. The cell lysates were immunoprecipitated with anti-Pten and blotted with anti-Ub. The membranes were stripped and reprobed with anti-Pten. The
numbers below each lane represent the optical density of the Pten band in arbitrary densitometric units determined by the LI-COR Odyssey Infrared Imaging
System.
(B)WT andCbl-b/ T cells were stimulated with anti-CD3 plus anti-CD28 for 12, 24, 72, and 96 hr, and lysed. The cell lysates were blottedwith anti-Pten and anti-
actin, respectively. The numbers below each lane of the Pten bands represent the optical density in arbitrary densitometric units determined by the LI-COR
Odyssey Infrared Imaging System (upper panel). The RNA was extracted from WT and Cbl-b/ T cells stimulated as in (A), and Pten mRNA expression was
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Loss of Cbl-b Facilitates the Association of Pten
with Nedd4
The data described above suggest that Cbl-b may regulate the
association of Pten with Nedd4. To assess this possibility, we
examined the association of Pten with Nedd4 in the presence
or absence of Cbl-b in T cells. A small amount of Pten constitu-
tively associated with Nedd4 in WT T cells, and this association
was increased upon TCR stimulation (Figure 6A). In the absence
of Cbl-b, the association of Pten with Nedd4 induced by TCR
stimulation was significantly increased (Figure 6A). These data
support the notion that Cbl-b inhibits downregulation of Pten
activation by impeding the binding of Pten to Nedd4, which
results in attenuated levels of Pten ubiquitination. To further
prove this notion, we performed a GST-Nedd4 pull-down assay
using Cbl-b/ T cell lysates in the presence of increasing
amounts of Cbl-b. As shown in Figure 6B, GST-Nedd4, but not
GST, bound to Pten. As expected, the association of Pten with
Nedd4 declined in a Cbl-b dose-dependent manner (Figure 6B).
To affirm the relationship among Cbl-b, Nedd4, and Pten, we
utilized T cells lacking Nedd4 (Figure 6C). Ablation of Nedd4
abrogated the association ofCbl-bwith Pten (Figure 6B), support-
ing the notion that Cbl-b associateswith Pten viaNedd4. It should
be noted that althoughPten constitutively associatedwithNedd4,
Pten ubiquitination was very low at the basal levels, suggesting
that Nedd4 activation requires TCR triggering (Figure 3A). It is
possible that TCR stimulation may induce some conformation
changes in Nedd4 to induce its Ub ligase activity. Our data also
suggest that Nedd4 positively regulates T cell activation, consis-
tent with the report that Nedd4 augments adaptive immune
response as observed by Yang et al. (2008). Indeed, we found
that Nedd4/ T cells displayed defective downregulation of
Pten activation and impaired Akt phosphorylation in response to
TCR stimulation. However, TCR-induced phosphorylation of
ERK, JNK, and p38 MAPK was intact (Figures 6D and 6E). In
support of this observation, Nedd4/ T cells proliferated poorly
and produced little IL-2 upon TCR or TCR/CD28 stimulation (Fig-
ure S4A). Note that Cbl-b expression was elevated in T cells lack-
ingNedd4,which is consistentwithaprevious report byYangetal.
(2008), whereas Pten expression was not altered (Figure S4B).determined by real-time RT-PCR. The results were expressed as fold changes in
correction for loading differences (lower panel).
(C) WT and Cbl-b/ T cells were stimulated and lysed as in (A). The cell lysates (C
membranes were stripped and reprobed with anti-Pten (upper panel). The numbe
densitometric units. Alternatively, DO11.10 T cells were transiently transfected w
Flag-tagged Pten, and stimulated with anti-CD3 and anti-CD28. The cell lysates w
were blotted with anti-Flag and anti-Myc, respectively (lower panel). IB, immuno
(D) WT and Cbl-b/ T cells were pretreated with MG-132 and stimulated as in the
Ub and reprobedwith anti-Nedd4 (upper panel). WT andCbl-b/ T cells were stim
were blotted with anti-Nedd4 and anti-actin, respectively (lower panel).
(E) GST-Nedd4 was incubated with E1, Ubc5, and Ub in the presence or absence
with HA-tagged Cbl-b or HA-tagged Cbl-b C373A mutant using mMAC columns. T
membrane was stripped and reprobed with anti-HA and anti-Nedd4, respectivel
(F)WT andCbl-bC373A T cells were stimulatedwith anti-CD3 or anti-CD3 plus anti-C
Akt (Ser473) and reprobed with anti-Akt.
(G) GST-Pten was incubated with Nedd4 isolated from WT T cells unstimulated
His-K48 Ub, or His-K63 Ub in the presence or absence of purified Cbl-b or Cbl-b
purified by anti-GST immunoprecipitation, and ubiquitination of Pten was visualize
respectively.
The data are representative of at least two (C and D) or three (A, B, and E–G) indIntroducing Nedd4 Deficiency into Cbl-b/ Mice
Inhibits Hyperactivity of Cbl-b/ T Cells
Our data suggest that Pten lies downstream of Cbl-b, which
inhibits inactivation of Pten via Nedd4. One would expect that
introducingNedd4 deficiency intoCbl-b/micewould abrogate
hyperactivity of Cbl-b/ T cells. To test this, we generated WT,
Cbl-b/, Nedd4/, and Cbl-b/Nedd4/ fetal liver chimeras.
The peripheral T and B cell compartments in Nedd4/ and
Cbl-b/Nedd4/ chimeric mice were normal (data not shown).
We immunizedWT, Cbl-b/, Nedd4/, and Cbl-b/Nedd4/
chimeric mice with OVA in complete Freund’s adjuvant (CFA). To
monitor in vivo T cell proliferation, we injected the mice with
BrdU at day 4 for 3 consecutive days, and T cell proliferation
was determined by measuring BrdU incorporation with flow cy-
tometry. The in vitro T cell proliferation and cytokine production
by T cells fromWT, Cbl-b/, Nedd4/, and Cbl-b/Nedd4/
chimeric mice during the recall response were determined at
7 days after the immunization. We found that loss of Nedd4
completely inhibits the hyperproliferation of Cbl-b/ T cells
in vivo and in vitro (Figure 7A), and abrogates hyper-IL-2 pro-
duction by Cbl-b/ T cells (Figure 7B), which correlated with
the impaired downregulation of Pten activity, defective Pten
ubiquitination, and decreased Akt phosphorylation observed in
Cbl-b/Nedd4/ T cells (Figures 7C and 7D). Collectively,
our data generated from fetal liver reconstitution support the
notion that Cbl-b and Nedd4 may regulate each other: Cbl-b
regulates Nedd4 Ub ligase activity, whereas Nedd4 destabilizes
Cbl-b in T cells. Our data suggest that hyper-T cell activity
caused by the loss of Cbl-b is suppressed in the absence of
Nedd4, possibly by the restoration of Pten activity.
DISCUSSION
It has been suggested that Cbl-b negatively regulates T cell acti-
vation by targeting PI3K p85 for ubiquitination (Fang and Liu,
2001; Fang et al., 2001). However, direct analysis of PI3K activity
upon TCR or CD28 costimulation in the presence or absence of
Cbl-b has been lacking. In this study we demonstrate that Cbl-b
does not regulate PI3K but rather inhibits the Ub ligase activity ofthe levels of PtenmRNA compared with the unstimulated control sample, after
L) were immunoprecipitated with anti-Pten and blotted with anti-K63 Ub. The
rs below each lane of the Pten bands represent the optical density in arbitrary
ith Myc-tagged Nedd4 and HA-tagged Ub, Ub K48R, or K63R, together with
ere immunoprecipitated with anti-Flag and blotted with anti-HA. The cell lysates
blot; IP, immunoprecipitate.
upper panel of (A), immunoprecipitated with anti-Nedd4, and blotted with anti-
ulatedwith anti-CD3 and anti-CD28 for 0, 24, 48, 72, and 96 hr. The cell lysates
of Cbl-b or Cbl-b C373A protein purified from 293T cells transiently transfected
he autoubiquitination of Nedd4 was detected by anti-Ub immunoblotting. The
y.
D28 for 1 and 5min, and lysed. The cell lysates were blottedwith antiphospho-
or stimulated with anti-CD3 and anti-CD28 together with E1, E2, and His-Ub,
C373A protein. The reaction was terminated by cold RIPA buffer. The Pten was
d by anti-Ub Ab. The membrane was reprobed with anti-GST and anti-Nedd4,
ependent experiments. See also Figure S3.
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Figure 5. Loss of Cbl-b Facilitates Pten Translocation from the
Plasma Membrane to the Cytoplasm
(A) WT and Cbl-b/ T cells were stimulated with anti-CD3 or anti-CD3 plus
anti-CD28 for 5 min and lysed in hypotonic lysis buffer. The cytosolic and
membrane fractions were separated. The expression of Pten in the cytosolic
and membrane fractions was determined by anti-Pten immunoblotting. The
membrane was stripped and reprobed with anti-Lck.
(B) DO11.10 T cells were transfected with Flag-tagged Myr-Pten or WT Pten,
stimulated with anti-CD3 and anti-CD28, and lysed. The cell lysates were
immunoprecipitated with anti-Flag, and Pten catalytic activity was determined
as in Figure 2B. An aliquot of cell lysates was blotted with anti-Flag. IB,
immunoblot.
The data are representative of two independent experiments.
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Figure 4. Lysine 13 Is a Major Site for Pten Polyubiquitination in
T Cells
(A) DO11.10 T cells were transfected with HA-tagged Pten or Pten K289R or
K13R mutant together with Myc-tagged Nedd4 and His-tagged Ub. The
478 Cell Reports 1, 472–482, May 31, 2012 ª2012 The AuthorsNedd4, which targets Pten for K63-linked polyubiquitination,
thus suppressing inactivation of Pten. Cbl-b may exert its effect
on Pten by impeding the binding of Pten to Nedd4, which is inde-
pendent of its E3 Ub ligase activity (Figure S5). This signaling
pathway, which is normally mediated by CD28 costimulation,
is turned on when TCR signaling is present in the absence of
Cbl-b. Our data suggest that the uncoupling of CD28transfected cells were stimulated with anti-CD3 and anti-CD28, or left un-
stimulated, and lysed in RIPA buffer. The cell lysates were immunoprecipitated
with anti-HA and blotted with anti-His. The cell lysates were blotted with anti-
HA and anti-Myc as loading controls. IB, immunoblot; IP, immunoprecipitate.
(B) The aliquots of anti-HA immunoprecipitates from (A) were used for the Pten
activity assay described in Figure 2B.
(C) DO11.10 T cells were transfected with HA-tagged Pten or Pten K289R or
K13R mutant and stimulated as in (A). The transfected cells were fixed, per-
meabilized, and then stained with PE-rat anti-CD4 and rabbit anti-HA followed
by Alexa Fluor 488-donkey anti-rabbit IgG. Hoechst 33342 stained nuclei.
The data are representative of three independent experiments.
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Figure 6. Cbl-b Inhibits the Association of Pten with Nedd4 in T Cells
(A) WT and Cbl-b/ T cells were stimulated with anti-CD3 or anti-CD3 plus anti-CD28 and lysed in 0.5% NP-40 lysis buffer. The cell lysates were immuno-
precipitated with anti-Pten and blotted with anti-Nedd4, anti-Cbl-b, and anti-Pten, respectively (upper panel). Alternatively, the cell lysates were immunopre-
cipitated with anti-Nedd4 and blotted with anti-Pten, anti-Cbl-b, and anti-Nedd4, respectively (lower panel). IP, immunoprecipitate.
(B) GST-Nedd4 was incubated with Cbl-b/ T cell lysates in increasing amounts of Cbl-b protein and followed by glutathione Sepharose beads. GST alone was
used as a negative control. Cbl-b and Pten binding to GST-Nedd4 was detected by immunoblotting.
(C) Nedd4+/+ and Nedd4/ T cells were stimulated with anti-CD3 plus anti-CD28 and lysed. The cell lysates were immunoprecipitated with anti-Pten and blotted
with anti-Cbl-b, anti-Nedd4, and anti-Pten, respectively. The expression of Nedd4 in T cell lysates from Nedd4+/+ and Nedd4/ mice was determined by anti-
Nedd4 immunoblotting.
(D) Pten activity in Nedd4+/+ and Nedd4/ T cells before and after TCR stimulation was determined as in Figure 2B. The cell lysates were blotted with anti-Pten.
(E) The phosphorylation of Akt, ERK, JNK, and p38MAPK in T cells fromNedd4+/+ and Nedd4/mice before and after TCR/CD28 stimulation was determined by
specific phospho-Abs. The membranes were stripped and reprobed with anti-Akt or anti-actin.
The data are representative of at least three independent experiments.costimulation from this process via Cbl-b deficiency may occur
at least in part at the level of Pten. In addition our data also indi-
cate that Cbl-b regulates T cell activation via both Ub ligase-
dependent and -independent mechanisms.
Although PI3K has been implicated in CD28 costimulatory
signaling activity, this conclusion ismainly based upon Akt phos-
phorylation and PIP3 levels in CD28 or phosphotyrosine immu-
noprecipitates as surrogate indicators for PI3K activity (Cai
et al., 1995; Hutchcroft et al., 1995; Lu et al., 1994; Naramura
et al., 1998; Page`s et al., 1996). Surprisingly, both p85 and
Pten are found in TCR-z and CD28 immunoprecipitates (Fig-
ure S2B), suggesting that the effect of PI3K activity in the
CD28 signaling pathway should be reevaluated. In keeping
with this finding, p85 has been found to associate with Pten
complex (Rabinovsky et al., 2009; Chagpar et al., 2010). More-
over, we found that CD28 does not promote TCR-induced
activation of PI3K (Figures 2A and 2B). The augmented level ofPIP3 in the cells induced by CD28 costimulation is rather due
to further downregulation of Pten activity upon TCR stimulation
(Figure 2C). In support of this observation, loss of Pten in
T cells uncouples the requirement of CD28 costimulation for
proliferation and IL-2 production (Buckler et al., 2006).
Our data show that the absence of Cbl-b does not result in
heightened activation of PI3K in response to TCR stimulation,
suggesting that elevated levels of PIP3 and Akt phosphorylation
may be due to decreased activation of Pten. Indeed, TCR-
induced Pten activity is significantly downregulated in T cells
lacking Cbl-b, and CD28 costimulation does not further downre-
gulate Pten (Figure 2C). Cbl-b was previously shown to target
PI3K p85 for ubiquitination but not degradation, and ubiquiti-
nated p85 fails to bind to TCR-z and CD28 (Fang and Liu,
2001). However, using T cells lacking Cbl-b, we showed that
PI3K p85 ubiquitination is not impaired in primary T cells (Fig-
ure S2A). Instead, we found that Cbl-b inhibits the Ub ligaseCell Reports 1, 472–482, May 31, 2012 ª2012 The Authors 479
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Figure 7. Introducing Nedd4 Deficiency into Cbl-b/ Mice Abrogates Hyper-T Cell Activity in Cbl-b/ Mice
(A) WT, Cbl-b/, Nedd4/, andCbl-b/Nedd4/ fetal liver chimeric micewere immunized withOVA in CFA by s.c. injection at 8 weeks after reconstitutionwith
fetal liver cells. The mice were then injected with BrdU on day 4 every 12 hr for 3 consecutive days and sacrificed on day 7. In vivo splenic T cell proliferation was
measured using BrdU staining and analyzed by flow cytometry.
(B) The splenic T cells isolated from the immunized animals were cultured in the presence of irradiated WT T-depleted splenocytes pulsed with OVA (200 mg/ml).
T cell proliferation was determined by [3H]thymidine incorporation, and IL-2 production in the culture supernatants was measured by ELISA. **p < 0.005,
compared Cbl-b/ with Nedd4/ or Cbl-b/Nedd4/; *p < 0.05, compared WT with Nedd4/ or Cbl-b/Nedd4/; Student’s t test.
(C and D) T cells fromWT, Cbl-b/, Nedd4/, and Cbl-b/Nedd4/ fetal liver chimeric mice were stimulated with anti-CD3 for 5 min or left unstimulated, and
lysed. The cell lysates were immunoprecipitated with anti-Pten, and the Pten catalytic activity was determined as in Figure 2B (C). The Pten ubiquitination was
detected by anti-Ub immunobltting. An aliquot of the cell lysates was blotted with anti-phospho-Akt (S473), anti-Pten, and anti-actin, respectively (D).
The data are representative of two independent experiments.activity of Nedd4, which targets Pten for ubiquitination (Figure 3)
and facilitates its cytosolic translocation (Figure 5A), and that
Cbl-b exerts its inhibitory effect on Pten ubiquitination by
impeding the binding of Pten to Nedd4 (Figure 6). These data
are supported by the evidence that T cells expressing Cbl-b
C373A mutation display normal activation of Akt in response
to TCR stimulation (Figure S3). Our data are consistent with
a recent report that Rak was found to inhibit the binding of
Pten to Nedd4 in cancer cell lines (Yim et al., 2009). It has
been shown that the Cbl-b proline-rich region and TKB domain
may bind to theWWdomain and C2 domain of Nedd4 (Magnifico
et al., 2003) and that Nedd4 may bind to Pten via interaction
between C2 domains in Nedd4 and Pten (Wang et al., 2008). It
is possible that Cbl-b impedes the binding of Pten to Nedd4 by
disrupting C2 domain interaction between Nedd4 and Pten,
thus modulating Pten activation. Indeed, Nedd4/ T cells
show defective T cell proliferation and IL-2 production and adap-
tive immunity (Yang et al., 2008), which differ from the pheno-
types of Itch/ and Cbl-b/ mice (Bachmaier et al., 2000;
Chiang et al., 2000; Fang et al., 2002; Heissmeyer et al., 2004).
Nedd4 deficiency completely abrogates hyper-T cell activity in
Cbl-b/ mice (Figure 7).480 Cell Reports 1, 472–482, May 31, 2012 ª2012 The AuthorsNedd4 has been shown to target Pten for ubiquitination and
degradation in cancer cell lines (Wang et al., 2007). Consistent
with this observation, Rak-1 tyrosine kinase has been shown to
inhibit the binding of Pten to Nedd4 and inhibits Nedd4-
mediated Pten ubiquitination and degradation in cancer cells
(Yim et al., 2009). Furthermore, Nedd4-mediated Pten ubiquiti-
nation in vitro inhibits its phosphatase activity (Maccario et al.,
2010). Our data show that although there is increased binding
of Pten to Nedd4 in the absence of Cbl-b, Pten protein is still
stable in Cbl-b/ T cells (Figure 3B). Pten has been reported
to be induced by CD28 stimulation in human CD4+ T cells at
mRNA and protein levels (Schmidt-Weber et al., 2002), but
Pten appeared to be downregulated upon CD28 costimulation
in mouse T cells that might be targeted by miR-214 (Jindra
et al., 2010). We found that there is no significant decrease in
the expression of Pten at either mRNA or protein levels (Fig-
ure 3B). Using Nedd4/ mouse embryonic fibroblasts (MEFs)
or T cells, several groups showed that loss of Nedd4 does not
alter Pten protein stability (Cao et al., 2008; Fouladkou et al.,
2008; Yang et al., 2008), which is consistent with our observation
that Pten does not undergo degradation upon TCR/CD28 stimu-
lation (Figure 3B). Indeed, we found that K13 of Pten undergoes
K63-linked polyubiquitination in T cells (Figures 3C and 4A),
which may increase the cytoplasmic pool of Pten (Figure 5A),
thus down-modulating Pten activity (Figure 6D). Nevertheless,
insulin-induced Akt phosphorylation is greatly impaired in
MEFs lacking Nedd4 (Cao et al., 2008), suggesting that Nedd4
positively regulates Akt activation. In support of a role for
Nedd4 in Akt activation in T cells, we found that Nedd4/
T cells display impaired Pten inactivation and defective Akt
phosphorylation in response to TCR/CD28 stimulation (Fig-
ure 6D). Collectively, our data support the notion that Nedd4
regulates Pten activity via a K63-linked polyubiquitination in
T cells and that Cbl-b inhibits this process.
In summary this study demonstrates that hyperactivation
of Akt induced by TCR stimulation in Cbl-b/ T cells is not due
to enhanced PI3K activity but rather downregulation of Pten acti-
vation. Cbl-b associates with Nedd4 and inhibits autoubiquitina-
tion of Nedd4, which targets Pten for K63-linked ubiquitination,
thus inhibiting downregulation of Pten activity. Therefore, we
have identified a mechanism by which Cbl-b regulates the
CD28-mediated PI3K/Akt pathway during T cell activation.
EXPERIMENTAL PROCEDURES
Mice
WT BALB/c mice were purchased from The Jackson Laboratory (Frederick,
MD, USA). Cbl-b/ mice were described previously by Bachmaier et al.
(2000) and have been backcrossed onto the BALB/c background for 14
generations. Cbl-bC373Amicewere generated by a targeting vector introducing
the Cys (TGC) to Ala (GCG) substitution at amino acid 373 using PCR
fragments generated from 129Sv/J genomic DNA (Oksvold et al., 2008).
Nedd4Gt(IRESBetageo)249Lex mice (hereafter Nedd4+/) were generated by
Lexicon Genetics via retroviral insertion strategy by Raymond and Soriano
(2006). We have obtained Nedd4+/ mice that are viable, fertile, and devoid
of gross phenotypic defects (http://www.mmrrc.org/strains/11742/011742.
html). As reported previously, most Nedd4/ mice die at birth (Fouladkou
et al., 2008; Yang et al., 2008), but a few do escape neonatal death. All
experimental protocols followed NIH Guidelines and were approved by the
University of Chicago Institutional Animal Care and Use Committee. All mice
were used for experiments at ages of 6 to 10 weeks.
Generation of Cbl-b/, Nedd4/, and Cbl-b/Nedd4/ Fetal Liver
Chimeras
Fetal liver cell suspensions from WT, Cbl-b/, Nedd4/, and
Cbl-b/Nedd4/ embryos at days 14–16 were transferred by injection into
the tail veins of lethally irradiated 6- to 10-week-old C57BL/6 recipients that
had received 950 rads.
Immunoprecipitation, Affinity Precipitation, and Western Blotting
The conditions for immunoprecipitation and immunoblotting were described
previously by Zhang et al. (2002), Li et al. (2004), and Qiao et al. (2008).
GST-Nedd4 protein was incubated with Cbl-b/ T cell lysates in the presence
of increasing amounts of HA-Cbl-b followed by glutathione Sepharose beads.
The binding of Pten and Cbl-b to GST-Nedd4 was detected by immunoblot-
ting. The band density was measured by LI-COR Odyssey Infrared Imaging
System (Lincoln, NE, USA).
Statistical Analysis
All data presented with statistical analysis were analyzed using a Student’s
t test. All tests were assessed at the 0.05 level of significance.
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